👾Diabetes in China 〜 Publications / by Swiss Re
💊Sumitomo Dainippon Pharma and Poxel Announce Strategic Partnership for Development and Commercialization of Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan, China and Eleven Other Asian Countries
🎮YouTube TV announces dedicated TV apps, coming soon to Apple TV, smart TVs, and more
📸Sony Seeks Blockchain Patent for User Authentication System
📸Nikon to Discontinue Operations of a Consolidated Chinese Manufacturing Subsidiary of Imaging Business